Description

Ovarian Cancer Diagnostics Market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report gives historical, current, and future market sizes (US$ Mn) of diagnosis type, disease type, and end user and distribution channel and geographic regions. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the market report include suppliers, manufacturers, marketers, policymakers.Ovarian Cancer Diagnostics is a disease characterized by the abnormal growth of cells in the ovarian tissue. Ovarian Cancer Diagnostics Market is the most common type of cancer in women. Types of ovarian cancer include a stromal tumour, germ cell tumour, and epithelial tumours. Symptoms associated with ovarian cancer include abdominal pressure, swelling, loss of appetite, urinary urgency, low back pain, and pelvic discomfort among others. Ovarian cancer can be diagnosed by MRI, CT, PET scans, blood tests, ultrasound, and pelvic examination. In May 2015, Abcodia secured funding about £5.25 Mn to launch Roca test for early detection of the ovarian cancer

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX